Activity of different phospholipids in attenuating hyperactivity in bladder irritation
Pradeep Tyagi1, Michael Chancellor, Naoki Yoshimura
1Department of Pharmaceutical sciences, School of Pharmacy, University of Pittsburgh, PA, USA.
BJU International
|December 12, 2007
Summary
Uncharged phospholipids in liposomes effectively reduced bladder hyperactivity in a rat model after injury. Optimal liposome efficacy for bladder irritation involved specific phosphatidylcholine structures.
Area of Science:
- Pharmacology
- Biochemistry
- Urology
Background:
- Bladder hyperactivity is a common condition.
- Liposomes are potential drug delivery systems.
- Understanding lipid structures is crucial for therapeutic efficacy.
Purpose of the Study:
- To assess liposomes made from natural and synthetic lipids for treating rat bladder injury.
- To identify key structural features of liposomes for alleviating bladder hyperactivity.
- To investigate the role of cholesterol in liposome efficacy.
Main Methods:
- Rat bladder injury model induced by protamine sulfate (PS) and potassium chloride (KCl).
- Intravesical pressure and cystometrograms (CMGs) recorded in anesthetized rats.
- Liposomes of varying lipid compositions infused to evaluate reduction in bladder contraction frequency (BCF).
Main Results:
- Uncharged zwitterionic phospholipid liposomes significantly reduced PS-induced bladder irritation and hyperactivity.
- Cationic or anionic charged lipid liposomes showed no significant effect.
- Cholesterol addition did not enhance liposome efficacy.
- Optimal liposome efficacy observed with phosphatidylcholines possessing longer acyl chains and mono-unsaturation.
Conclusions:
- Phospholipids, particularly uncharged zwitterionic ones, can attenuate bladder irritation following injury.
- Liposome structure, specifically acyl chain length and saturation, is critical for therapeutic effect in bladder hyperactivity.
Related Concept Videos
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:20Drugs Affecting GI Tract Motility: Other Laxatives
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:23Membrane Fluidity
Cell membranes are composed of phospholipids, proteins, and carbohydrates loosely attached to one another through chemical interactions. Molecules are generally able to move about in the plane of the membrane, giving the membrane its flexible nature called fluidity. Two other features of the membrane contribute to membrane fluidity: the chemical structure of the phospholipids and the presence of cholesterol in the membrane.Fatty acids tails of phospholipids can be either saturated or...